FEM1A is a candidate gene for polycystic ovary syndrome

Gynecological Endocrinology

Volumn 21, Issue 6, 2005, Pages 330-335

  Maher, Joseph F ^a,e   Hines, Randall S ^a   Futterweit, Walter ^b   Crawford, Shawana ^c   Lu, Deyin ^a   Shen, Peidong ^d   Oefner, Peter ^d   Kazi, Mohammed ^a   Wilson, James G ^a   Subauste, Jose S ^a   Cowan, Bryan D ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Jackson State University   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetes; fem 1; Genetics; Hyperandrogenism; Polycystic ovary syndrome

Indexed keywords

AMINO ACID; PROTEIN; PROTEIN FEM1A; UNCLASSIFIED DRUG;

ALLELE; ANDROGEN SYNTHESIS; ARTICLE; CAENORHABDITIS ELEGANS; CAUCASIAN; CHROMOSOME 19P; CONTROLLED STUDY; ENDOCRINE DISEASE; ETHNOLOGY; FEMALE; GENDER AND SEX; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; IMMUNOHISTOCHEMISTRY; INFERTILITY; INSULIN RESISTANCE; LEYDIG CELL; MASCULINITY; MISSENSE MUTATION; MOUSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SKELETAL MUSCLE;

CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; OPEN READING FRAMES; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION;

EID: 30344486569     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590500431458     Document Type: Article

References (32)

1. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002;78:569-576.
2. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-1236.
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
5. Chang RJ, Katz SE. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:397-408.
6. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002; 77:1095-1105.
7. Venkatesan AM, Dunaif A, Corbould A. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res 2001;56:295-308.
8. Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001;7: 405-410.
9. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 1999;96:8573-8578.
10. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 2001;86:446-449.
11. Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R, Tomer Y. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril 2002;78:1240-1243.
12. Strauss JF 3rd. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci 2003;997:42-48.
13. Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18: 707-718.
14. Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JF 3rd, Dunaif A, Spielman RS, Legro RS. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003;52:214-217.
15. Doniach T, Hodgkin J. A sex-determining gene, fem-1, required for both male and hermaphrodite development in Caenorhabditis elegans. Dev Biol 1984;106:223-235.
16. Spence AM, Coulson A, Hodgkin J. The product of fem-1, a nematode sex-determining gene, contains a motif found in cell cycle control proteins and receptors for cell-cell interactions. Cell 1990;60:981-990.
17. Ventura-Holman T, Hahn H, Subauste JS, Maher JF. The Fem1a gene is down-regulated in rhabdomyosarcoma. Tumor Biology 2005;26:294-299.
18. Ventura-Holman T, Seldin MF, Li W, Maher, JF. The murine Fem1 gene family: homologs of the Caenorhabditis elegans sex-determination protein FEM-1. Genomics 1998;54:221-230.
19. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995; 96:801-810.
20. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 2001;281:E392-E399.
21. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A. Insulin resistance in the skeletal muscle of women with polycystic ovary syndrome involves both intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 2005;288:E1047-E1054.
22. Azziz R. Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril 2003;80:252-254.
23. McCartney CR, Bellows AB, Gingrich MB, Hu Y, Evans WS, Marshall JC, Veldhuis JD. Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2004;286:E902-E908.
24. Nelson VL, Legro RS, Strauss JF 3rd, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999;13:946-957.
25. Magoffin DA, Erickson GF. Primary culture of differentiating ovarian androgen-producing cells in defined medium. J Biol Chem 1982;257:4507-4513.
26. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/ function relationships. Endocr Rev 1985;6:371-399.
27. Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, Hsueh AJ, Tsafriri A. Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod 2000;63:1214-1218.
28. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001;27:234-236.
29. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004;305:869-872.
30. Raymond CS, Murphy MW, O'Sullivan MG, Bardwell VJ, Zarkower D. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 2000;14:2587-2595.
31. Lu D, Ventura-Holman T, Li J, McMurray RW, Subauste JS, Maher JF. Abnormal glucose homeostasis and pancreatic islet function in mice with inactivation of the Fem1b gene. Mol Cell Biol 2005;25:6570-6577.
32. Wade GN, Schneider JE, Li HY. Control of fertility by metabolic cues. Am J Physiol. 1996;270:E1-E19.